British

Bicycle Therapeutics Announces Collaboration With the German Cancer Research Center, to Discover and Develop Wholly Owned Bicycle® Radio Conjugates for a Range of Oncology Targets

Retrieved on: 
torsdag, maj 4, 2023
Research, Clinical Trials, Biotechnology, Radiology, Health, Pharmaceutical, Other Science, Science, Oncology, BRC, University, Therapy, Cancer research, Biomedical Research, Radiochemistry, DKFZ, Leg, German Cancer Research Center, Bicycle, British, Novartis, Patient, University Hospital Heidelberg, Neoplasm, Pharmaceutical industry

Bicycle Therapeutics plc (NASDAQ: BCYC), a biotechnology company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle®) technology, today announced that it has entered into a collaboration with the German Cancer Research Center (DKFZ), to develop and discover Bicycle® radio conjugates (BRCs) for a range of oncology targets.

Key Points: 
  • Bicycle Therapeutics plc (NASDAQ: BCYC), a biotechnology company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle®) technology, today announced that it has entered into a collaboration with the German Cancer Research Center (DKFZ), to develop and discover Bicycle® radio conjugates (BRCs) for a range of oncology targets.
  • Bicycle and DKFZ have been collaborating on tumor targeting BRCs which in preclinical studies, have shown superior tumor uptake compared to antibody-based approaches.
  • Results from the preclinical study were published in Cancer Research in February 2019 and can be accessed here .
  • Professor Matthias Eder commented that he and his colleagues at DKFZ were excited to work with Bicycle to develop novel radiopharmaceutical therapies.

Arqit brings data security expertise to world-leading Centre for Digital Trade and Innovation

Retrieved on: 
tisdag, april 25, 2023
Private sector, Partnership, International, Financial Times Business Book of the Year Award, Tees Valley Combined Authority, Online Protection and Enforcement of Digital Trade Act, Government, UK Government G-Cloud, ICC, UNCITRAL Model Law on Electronic Transferable Records, International Chamber of Commerce, British, Fraud, Teesside University, Commerce, Legislation, Software, Cryptocurrency, Security (finance), Innovation

LONDON, April 25, 2023 (GLOBE NEWSWIRE) -- A security partnership between the Centre for Digital Trade and Innovation (C4DTI) and Arqit Quantum Inc. (Nasdaq: ARQQ, ARQQW) (“Arqit”) will deliver digitally secure, globally interoperable trade solutions.

Key Points: 
  • Leader in quantum-safe encryption technology brings security expertise to public-private partnership making trade cheaper, simpler, faster and more sustainable.
  • LONDON, April 25, 2023 (GLOBE NEWSWIRE) -- A security partnership between the Centre for Digital Trade and Innovation (C4DTI) and Arqit Quantum Inc. (Nasdaq: ARQQ, ARQQW) (“Arqit”) will deliver digitally secure, globally interoperable trade solutions.
  • This partnership will focus on security, with Arqit collaborating on the development of digitally secure and interoperable solutions that facilitate adoption of digital trading processes.
  • Fundamental to this innovation is ensuring the security and integrity of these digital processes, which malicious actors will undoubtedly target.

ISA to Host Energy-focused Cybersecurity Summit in Scotland

Retrieved on: 
tisdag, april 11, 2023
OT, Intelligence, International Society of Automation, Johns Manville, Innovation, Certification, US, Supply chain, United States Department of Homeland Security, Internet, Schneider Electric, ISA, Growth, British, International Society, Automation, Medical device, Arms industry, Saudi Aramco

Industrial cybersecurity summit to include global perspectives on supply chain and threat intelligence

Key Points: 
  • Aberdeen, Scotland--(Newsfile Corp. - April 11, 2023) - The International Society of Automation (ISA) - the leading professional society for automation and industrial cybersecurity - has announced its first-ever OT Cybersecurity Summit in Aberdeen, Scotland.
  • Focused on the rapid growth of operational technology (OT) cybersecurity challenges and opportunities, ISA will host the event on 31 May and 1 June 2023, with training sessions available on 29 and 30 May.
  • ISA sets many of the technical standards used in industrial automation, including ISA/IEC 62443 , the world's only consensus-based automation and control systems cybersecurity standards.
  • In addition to developing and maintaining these standards, ISA offers training and credentialing on cybersecurity; certifies products, processes, and systems through its ISASecure certification; and raises awareness about the importance of OT cybersecurity through its membership consortium, the ISA Global Cybersecurity Alliance (ISAGCA).

NATIONAL WOMEN'S ENTERPRISE WEEK: UK'S FIRST NATIONAL WEEK TO CELEBRATE WOMEN IN BUSINESS

Retrieved on: 
torsdag, april 13, 2023
Entrepreneurship, House of Lords, Small business, Marketing, Business, Woman, Mentorship, National Women's Law Center, VCS, Growth, British, House, Social media, Female, Dragons' Den

LONDON, April 13, 2023 /PRNewswire/ -- June 19-23 sees the launch of National Women's Enterprise Week (NWEW), the first ever UK wide celebration of female led businesses.

Key Points: 
  • LONDON, April 13, 2023 /PRNewswire/ -- June 19-23 sees the launch of National Women's Enterprise Week (NWEW), the first ever UK wide celebration of female led businesses.
  • For women this also means levelling up the numbers, as currently only one in four businesses is female owned or led.
  • Start making those vital connections with other women already running their own business and those who need advice to get going.
  • National Women's Enterprise Week is for everyone – because Britain will only fulfil its true potential when women fulfil theirs.

MHRA Grants ADvantage Therapeutics Innovative Licensing and Access Pathway (ILAP) Designation for Novel Lead Product AD04™ for Phase 2b Trial in Alzheimer’s Disease

Retrieved on: 
onsdag, april 5, 2023
Cognition, Inflammation, National Health Service, NICE, Clinical Dementia Rating, Health care, Quality of life, Coronavirus Scientific Advisory Board, Medication, Human, Brain, NHS Wales, England, Immunotherapy, Wales, Healthcare Improvement Scotland, Advantage, SMC, NHS Improvement, NPI, Patient, United Kingdom, NHS England, National Institute for Health and Care Excellence, NHS, AD, Innovation, Therapy, Neuropsychiatry, Safety, British, MHRA, Hippocampus, Pharmaceutical industry, Medical imaging, Agency

ILAP was established in 2021 to reduce the time to market for innovative medicines in the United Kingdom.

Key Points: 
  • ILAP was established in 2021 to reduce the time to market for innovative medicines in the United Kingdom.
  • In addition, patients are also considered key partners and the patient voice is integrated at every development stage.
  • “We are delighted that MHRA has recognized the potential of AD04™ at same time we are launching our confirmatory trial,” said Jeffrey Madden, chief executive officer of ADvantage.
  • We hope this AD04 trial with ILAP designation will bring us one step closer,” he concluded.

VIKING MARKS FLOAT OUT OF NEWEST EGYPT SHIP

Retrieved on: 
tisdag, april 11, 2023
UNESCO, University of Oxford, Crusader, Archive, Dendera, Petrie Museum of Egyptian Archaeology, Giza pyramid complex, National Commission for Museums and Monuments, Mosque, Post, Grand Egyptian Museum, Commitment, British, Kings, Muhammad Ali, Aswan, Ship, Ancient Egypt, Temple, Arab Contractors, Egyptian Collection of the Hermitage Museum, Collection, Earl, Museum, Oxford University Museum of Natural History, Water, Privilege (evidence), World Heritage Site, Pharaoh, Ashmolean Museum, LOS, Artifact, Al-Karak, Griffith Institute, Shipbuilding, Tourism, Vikings, Abu Simbel, Nefertari

LOS ANGELES, April 11, 2023 /PRNewswire/ -- Viking® (www.viking.com) today announced its newest ship for the Nile River—the 82-guest Viking Aton—was "floated out," marking a major construction milestone and the first time the ship has touched water. Set to debut in August 2023, the Viking Aton will join the company's growing fleet of state-of-the-art ships purpose-built for the Nile River and sail Viking's bestselling 12-day Pharaohs & Pyramids itinerary. Viking has seen very strong demand in Egypt, with the 2023 season now sold out and many 2024 sailing dates already sold out. The surge in demand has led Viking to open 2025 sailing dates sooner than originally expected.

Key Points: 
  • Set to Debut in Summer 2023, the New Viking Aton Continues to Build on Viking's Commitment to Egypt
    LOS ANGELES, April 11, 2023 /PRNewswire/ -- Viking® ( www.viking.com ) today announced its newest ship for the Nile River—the 82-guest Viking Aton —was "floated out," marking a major construction milestone and the first time the ship has touched water.
  • Viking has seen very strong demand in Egypt, with the 2023 season now sold out and many 2024 sailing dates already sold out.
  • Our guests are curious explorers, and Egypt remains a destination of great interest for its many cultural treasures," said Torstein Hagen, Chairman of Viking.
  • In addition to the Viking Osiris, the Viking Aton will join the Viking Ra , which launched in 2018.

HIMSS23: Community Health Network Reduces Medication Warnings by 250K & Increases Alert Acceptance Using FDB PatientFirst™ Solutions

Retrieved on: 
torsdag, april 6, 2023
MSN, Workflow, British, Abrazo Community Health Network, First Databank, FDB, QT, HIMSS, Organization, Fatigue, CDS, Community, MD, Patient safety, Patient, SAN, CST, Health, RN, McGill, Hyperkalemia, Safety, Nursing, Pharmaceutical industry, Medical device, United States Department of Agriculture South Building, Geography of Indiana

SOUTH SAN FRANCISCO, Calif., April 6, 2023 /PRNewswire/ -- FDB (First Databank, Inc.), the leading provider of drug knowledge that helps healthcare professionals make precise decisions, announced today that its customer Community Health Network, a nine-hospital health system in Central Indiana, will deliver an educational session at HIMSS23.

Key Points: 
  • By modifying these 10 alerts in the first year, Community Health Network reduced medication alert volume by 250,000 while decreasing the rate at which clinicians override such alerts from 92% to 76%.
  • Community Health Network is a growing, non-profit, integrated delivery network with more than 200 sites of care throughout its region including surgery centers, home care services, MedChecks, behavioral health, and employer health services.
  • To tackle this now more pressing alert challenge, Community extended its alert optimization initiative to include medication alerts and partnered with FDB to deploy FDB Targeted Medication Warnings with FDB CDS Analytics to help make these alerts more patient-specific and actionable.
  • This guidance reduces alert fatigue and helps caregivers take more meaningful action at the right moment in their workflow.

Leading humanist and renowned political scientist, Robert Putnam, selected as Claremont McKenna College's 2023 Commencement speaker

Retrieved on: 
tisdag, mars 28, 2023
Civic, International Political Science Association, Faculty, Learning, United Nations Security Council, National academy, University, Bowling Alone, College, Senior, Weatherhead Center for International Affairs, Public policy, Harvard University, CMC, National Humanities Medal, Karl Deutsch Award, American Dream, Humanities, Multimedia, Johan Skytte Prize in Political Science, Book, Better Together: Restoring the American Community, Democracy, Kennedy School, Collapse, British, Faculty (division), American Political Science Association, Claremont McKenna College, Harvard Faculty of Arts and Sciences, Industrial design, Management

CLAREMONT, Calif., March 28, 2023 /PRNewswire/ -- Claremont McKenna College (CMC) will celebrate its 75th Commencement ceremony and the Class of 2023 on May 13, with leading humanist and renowned political scientist, Robert Putnam, offering the keynote address.

Key Points: 
  • CLAREMONT, Calif., March 28, 2023 /PRNewswire/ -- Claremont McKenna College (CMC) will celebrate its 75th Commencement ceremony and the Class of 2023 on May 13, with leading humanist and renowned political scientist, Robert Putnam, offering the keynote address.
  • He has undergone a decades-long quest to understand what happened to America and to figure out what it will take to weave us back together.
  • At Harvard, Putnam taught international relations, comparative politics, and American politics, including a seminar discussing "Community in America."
  • Putnam is a member of the National Academy of Sciences, a Fellow of the British Academy, and past president of the American Political Science Association.

Bicycle Therapeutics Announces a Strategic Collaboration with Novartis to Discover, Develop and Commercialize Bicycle® Radio-Conjugates

Retrieved on: 
tisdag, mars 28, 2023
Biotechnology, Health, Pharmaceutical, Clinical Trials, Oncology, British, Therapy, Novartis, Radiopharmaceutical, Bicycle, Pharmaceutical industry

Bicycle Therapeutics plc (NASDAQ: BCYC), a biotechnology company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle®) technology, today announced that it has entered into a strategic collaboration agreement with Novartis to develop, manufacture and commercialize Bicycle® radio-conjugates (BRCs) for multiple agreed upon oncology targets.

Key Points: 
  • Bicycle Therapeutics plc (NASDAQ: BCYC), a biotechnology company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle®) technology, today announced that it has entered into a strategic collaboration agreement with Novartis to develop, manufacture and commercialize Bicycle® radio-conjugates (BRCs) for multiple agreed upon oncology targets.
  • “This collaboration builds on the groundbreaking clinical work we have been doing in the toxin conjugate field and provides new and additional validation for this unique technology,” said Kevin Lee, Ph.D., Chief Executive Officer of Bicycle Therapeutics.
  • “We look forward to working closely with Novartis to pioneer the discovery and development of potential new cutting-edge radiopharmaceutical cancer treatments based on Bicycles.
  • Bicycle will also be eligible to receive tiered royalties on Bicycle-based medicines commercialized by Novartis.

Travere Therapeutics Announces Late-Breaker Presentations of the Interim Analysis from the Phase 3 PROTECT Study of FILSPARI™ (Sparsentan) in IgA Nephropathy at the ISN World Congress of Nephrology and NKF Spring Clinical Meetings 2023

Retrieved on: 
torsdag, mars 23, 2023
Heart Protection Study, Safety, IgA nephropathy, Immunoglobulin A, ISN, Proteinuria, HIV disease progression rates, Congress, Focal segmental glomerulosclerosis, NKF, Risk, SAN, UPCR, Patient, British, Therapy, PROTECT, Disease, Pharmaceutical industry, FSGS, Nephrology

FILSPARI (sparsentan), a Dual Endothelin Angiotensin Receptor Antagonist (DEARA), recently received U.S. accelerated approval to reduce proteinuria in adults with primary IgAN at risk of rapid disease progression, generally a UPCR ≥1.5 g/g.

Key Points: 
  • FILSPARI (sparsentan), a Dual Endothelin Angiotensin Receptor Antagonist (DEARA), recently received U.S. accelerated approval to reduce proteinuria in adults with primary IgAN at risk of rapid disease progression, generally a UPCR ≥1.5 g/g.
  • FILSPARI (sparsentan) is continuing to advance to the two-year confirmatory endpoints in the ongoing PROTECT Study and sparsentan is also in Phase 3 clinical development for the treatment of focal segmental glomerulosclerosis (FSGS).
  • The Company and its collaborators will also present baseline characteristics across patient populations participating in the PROTECT Study, as well as long-term clinical data from the ongoing open-label extension of the Phase 2 DUET Study of sparsentan in FSGS.
  • World Congress of Nephrology, Bangkok, Thailand – March 30-April 2, 2023
    Long-term Efficacy and Safety of Sparsentan in Young Patients with FSGS: 240-week Analysis of the DUET Open Label Extension
    Proteinuria and Its Association with Disease Progression in IgA Nephropathy: Analysis of the UK National RaDaR IgA Nephropathy Cohort